Bioscript Group

In pharma, data is everywhere - but is it truly being used to its full potential? Our Bioscript Data Insights (BDI) team ensures that scientific and strategic data isn’t just collected - it’s structured, analysed and applied to drive real impact. What does this mean in practice? ✅ Bringing together disparate data sources ✅ Identifying trends and patterns ✅ Refining stakeholder engagement strategies From unstructured to structured data - we help turn vast datasets into meaningful, actionable insights that drive success. See how we’ve done it in our case studies. 👇 🔹 https://loom.ly/T-hC43s 🔹 https://loom.ly/h_NaRng #DataAndInsights #BioscriptDataInsights #StrategicPlanning

Last week, our support services teams gathered in Manchester to celebrate their recent achievements and showcase their competitive edge with an exciting game of darts 🎯. This event truly highlighted what makes Bioscript a fantastic place to work - our commitment to people, collaboration, and shared success. We believe in fostering an environment where our employees can thrive both professionally and personally. By prioritising teamwork and individual growth, we ensure that everyone can be the best version of themselves, inside and outside of work. Here's to more moments of shared success and camaraderie! 🥂 #TeamCulture #MedComms #WorkplaceWellbeing

A well-defined scientific strategy isn’t static; it needs to flex and adapt while maintaining a strong foundation. At Bioscript Group, we help pharma teams build strategic scientific frameworks that connect data, evidence and messaging into a cohesive, enduring narrative. 📊 A key part of this is the scientific platform—which ensures that the pathways and decisions that need to be taken from early development to market expansion are grounded in a clear and aligned scientific story. Without this approach teams risk losing strategic continuity, leading to fragmented communication and weakened impact. We work with cross functional teams to ensure that the scientific strategy connects and is relevant to the overall brand and portfolio planning cycles and processes. Find out more 👉 https://loom.ly/QO4DtdU #MedicalAffairs #Pharma #MedComms

Strategic planning in pharma isn’t a one-year exercise—but annual budget cycles often shift the focus from long-term objectives to short-term tactics. While decision-makers plan with a multi-year vision, the challenge lies in maintaining strategic continuity as plans translate into yearly execution. In areas like market access communications, a lack of long-term alignment risks fragmented messaging, inconsistent data use and missed opportunities to shape access pathways. By integrating data analytics, pharma can move beyond reactive decision-making. Continuous measurement and real-time insights help refine strategies, ensuring engagement with stakeholders remains effective throughout a treatment’s lifecycle. Instead of asking, "What should we do this year?", the real question is, "How does this year fit into the long-term plan?" We help pharma teams answer these questions—ensuring strategy stays connected, measurable, and built for long-term success. Let’s talk. 👉 https://loom.ly/FgfOZeE #StrategicPlanning #PharmaStrategy #DataAndInshts

At Bioscript, we are committed to leading the industry with the latest insights and innovations. For this month of prostate cancer awareness and in advance of EAU 2025, we took a deep dive into the evolving landscape of prostate cancer. Led by Sarah Reynolds, Director, our teams performed both qualitative and quantitative research with prostate cancer specialists from the US and EU5, gaining invaluable insights into: ✅ Real perceptions of HCPs towards current treatments ✅ New diagnostic techniques ✅ The future of prostate cancer management Download a copy of our landscape review here 👉 https://loom.ly/gJcp3M8 and get in touch for a deep dive with our team into product and market-specific insights! #ProstateCancerAwarenessMonth #Oncology #HealthComms

Regulatory writing is more than document preparation—it’s about collaborating with stakeholders to deliver clear and compelling evidence to meet evolving regulatory expectations and keep drug development on track. At Bioscript Group, our approach is built on: ✅Senior-level expertise - A team consisting of a high proportion of experienced Senior and Principal Writers who understand the complexities of regulatory submissions ✅Flexible resourcing – An agile team structure that scales up or down as timelines shift ✅Integrated project management – Writers who integrate fully into client teams, leading where required, to maintain momentum and meet timelines ✅Robust quality control – Dedicated QC specialists ensure accuracy and consistency across all documents While AI is beginning to streamline document preparation, our skilled regulatory writers remain essential—interpreting complex data, managing cross-functional input and ensuring submissions meet regulatory expectations with clarity and precision. Follow the link to learn more about our regulatory writing services👉 https://lnkd.in/eRF_nPQJ #RegulatoryWriting #Pharma #ScientificCommunication

We have arrived at the European Association of Urology 2025 Congress! We are particularly excited to hear about pioneering new approaches in Non-Muscle Invasive Bladder Cancer (NMIBC), such as: 🔹RAG-01, a novel small activating RNA therapeutic 🔹Bel-sar (AU-011), a virus-like-drug-conjugate We will also be keeping an eye on updates in the prostate cancer space following our recent landscape analysis, which will be available to download soon. Sarah Reynolds and Tobias Reynolds are on hand to discuss how we can apply our expertise and high-quality delivery to partner with you. Thank you to our teams who are on-site delivering scientific excellence for our clients. #EAU25 #Oncology #BioscriptGroup

We’re excited to announce that we have been named a Finalist in the British Data Awards 2025, with headline partner Data Literacy Academy for Healthcare Organisation of the Year! The British Data Awards is an annual quest to discover and celebrate the UK’s data success stories. A record of 448 entries were received for the fifth edition of the British Data Awards, which means that the competition proved exceptionally strong, so we’re especially pleased to be announced as a Finalist. Gabrielle Silver, Bioscript Group CEO, said "We are thrilled to be named a Finalist in the British Data Awards 2025. This recognition is a testament to the exceptional progress our Bioscript Data Insights team has made in advancing our data capabilities. Their dedication and innovative approach have significantly contributed to our success and, of course, in bringing life-changing therapeutics to patients. We are proud to celebrate their achievements. We look forward to continuing our journey and showcasing the strength of the Bioscript Group data and AI capabilities." Finalists will be celebrated, and Winners will be announced, on the 14th of May at an award ceremony in London. #BioscriptGroup #BritishDataAwards #BioscriptDataInsights #Data

The way we communicate scientific information with healthcare professionals is changing—fast. Engagement platforms are driving a shift towards data-driven interactions, enabling more targeted and adaptive engagement with healthcare professionals. With real-time insights, pharma companies can move beyond static engagement models—but the challenge lies in translating this data into actionable strategy. At Bioscript, our Data Insights (BDI) capability helps bridge this gap. By integrating specialist knowledge with tech-enabled analysis, we help organisations measure engagement, map key influencers, and refine communication strategies in real-time—ensuring data isn’t just collected but actively drives impact. How are you leveraging technology to enhance engagement? Let's talk 👉 https://loom.ly/FgfOZeE #DigitalHealth #PharmaInnovation #MedicalAffairs #MedComms

At Bioscript Group, we’re fortunate to have leaders like Alexandra Howard, Senior Account Director, who bring strategic thinking and deep therapeutic expertise to everything they do. Her motivation for oncology runs deep—after losing her mother to cancer, she was drawn to the field by the potential to support clients and bring life-changing innovations to patients. With a passion for problem-solving and delivering real value, Alexandra works closely with clients to ensure their goals are met with clarity, direction and high-quality execution. But she also challenges them to think beyond individual projects—helping to build cohesive, long-term narratives that resonate in an increasingly complex healthcare landscape. 👉 Swipe to learn more about her take on industry trends, challenges and advice for pharma companies. #Oncology #MedComms #MedicalAffairs #WomenInPharma #BioscriptGroup